BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12446115)

  • 1. Different HATS of the ING1 gene family.
    Feng X; Hara Y; Riabowol K
    Trends Cell Biol; 2002 Nov; 12(11):532-8. PubMed ID: 12446115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the ING family of PHD proteins in cancer.
    Gong W; Suzuki K; Russell M; Riabowol K
    Int J Biochem Cell Biol; 2005 May; 37(5):1054-65. PubMed ID: 15743678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phylogenetic analysis of the ING family of PHD finger proteins.
    He GH; Helbing CC; Wagner MJ; Sensen CW; Riabowol K
    Mol Biol Evol; 2005 Jan; 22(1):104-16. PubMed ID: 15356280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ING1 proteins differentially regulate histone acetylation.
    Vieyra D; Loewith R; Scott M; Bonnefin P; Boisvert FM; Cheema P; Pastyryeva S; Meijer M; Johnston RN; Bazett-Jones DP; McMahon S; Cole MD; Young D; Riabowol K
    J Biol Chem; 2002 Aug; 277(33):29832-9. PubMed ID: 12015309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING1 and ING2: multifaceted tumor suppressor genes.
    Guérillon C; Larrieu D; Pedeux R
    Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor suppressor ING1: structure and function.
    Cheung KJ; Li G
    Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ING1 induces apoptosis through direct effects at the mitochondria.
    Bose P; Thakur S; Thalappilly S; Ahn BY; Satpathy S; Feng X; Suzuki K; Kim SW; Riabowol K
    Cell Death Dis; 2013 Sep; 4(9):e788. PubMed ID: 24008732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.
    Doyon Y; Cayrou C; Ullah M; Landry AJ; Côté V; Selleck W; Lane WS; Tan S; Yang XJ; Côté J
    Mol Cell; 2006 Jan; 21(1):51-64. PubMed ID: 16387653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
    Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K
    Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
    Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
    Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities.
    Loewith R; Meijer M; Lees-Miller SP; Riabowol K; Young D
    Mol Cell Biol; 2000 Jun; 20(11):3807-16. PubMed ID: 10805724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological functions of the ING family tumor suppressors.
    Campos EI; Chin MY; Kuo WH; Li G
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2597-613. PubMed ID: 15526165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination.
    Thalappilly S; Feng X; Pastyryeva S; Suzuki K; Muruve D; Larocque D; Richard S; Truss M; von Deimling A; Riabowol K; Tallen G
    PLoS One; 2011; 6(6):e21065. PubMed ID: 21731648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
    Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG
    Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers.
    Tokunaga E; Maehara Y; Oki E; Kitamura K; Kakeji Y; Ohno S; Sugimachi K
    Cancer Lett; 2000 Apr; 152(1):15-22. PubMed ID: 10754201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p33ING1b and estrogen receptor (ER) alpha.
    Toyama T; Iwase H
    Breast Cancer; 2004; 11(1):33-7. PubMed ID: 14718790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the tumour suppressor p33 ING1b in human neoplasia.
    Nouman GS; Anderson JJ; Lunec J; Angus B
    J Clin Pathol; 2003 Jul; 56(7):491-6. PubMed ID: 12835293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.